Literature DB >> 26563194

The Challenge of Erectile Dysfunction Management in the Young Man.

Seth D Cohen1.   

Abstract

Erectile dysfunction (ED) in a young man is an important health problem that significantly impacts the patient's quality of life and can have a detrimental effect on his well-being and relationship with his partner. Erectile dysfunction or impotence is one of the few disorders that will bring a young man into the doctor's office. This review article focuses on the epidemiology, etiology, presentation, work-up, and treatment of young men (age ~20-40 years old) presenting with complaints of ED. It is important to identify the precise etiology of the ED before proceeding with further evaluation and treatment because the work-up can be invasive and costly. ED is estimated to affect 20 % of men above 40 years of age, with the incidence increasing with increasing age. Erectile dysfunction has traditionally been seen as an age-dependent problem; however, approximately 2 % of men are affected at 40 years of age but this may be a gross underestimation secondary to reporting bias. Because ED is traditionally seen in the aging male population, studies regarding ED tend to be more frequently carried out among middle-aged and elderly men rather than in young men. These studies underline how comorbidities such as diabetes mellitus, cardiovascular or neurological pathologies, and medication use are strongly linked with ED. In addition, ED has been described to be associated with obesity or physical inactivity. This review article summarizes the important information that all sexual medicine providers should be familiar with when diagnosing, counseling, and treating young men with erectile dysfunction.

Entities:  

Keywords:  Erectile dysfunction; Men’s health; Sexual medicine

Mesh:

Year:  2015        PMID: 26563194     DOI: 10.1007/s11934-015-0553-3

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  73 in total

Review 1.  Depression: perspectives from affective neuroscience.

Authors:  Richard J Davidson; Diego Pizzagalli; Jack B Nitschke; Katherine Putnam
Journal:  Annu Rev Psychol       Date:  2002       Impact factor: 24.137

Review 2.  ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association.

Authors:  M D Cheitlin; A M Hutter; R G Brindis; P Ganz; S Kaul; R O Russell; R M Zusman
Journal:  J Am Coll Cardiol       Date:  1999-01       Impact factor: 24.094

3.  The impact of disrupted childhood attachment on the presentation of psychogenic erectile dysfunction: an exploratory study.

Authors:  Ravi P Rajkumar
Journal:  J Sex Med       Date:  2015-01-08       Impact factor: 3.802

Review 4.  Phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  Culley C Carson; Tom F Lue
Journal:  BJU Int       Date:  2005-08       Impact factor: 5.588

5.  A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction.

Authors:  Irwin Goldstein; Andrew R McCullough; Leroy A Jones; Wayne J Hellstrom; Charles H Bowden; Karen Didonato; Brenda Trask; Wesley W Day
Journal:  J Sex Med       Date:  2012-01-16       Impact factor: 3.802

6.  [Direct arterial anastomosis on corpora cavernosa penis in the therapy of erective impotence].

Authors:  V Michal; R Kramár; J Pospíchal; L Hejhal
Journal:  Rozhl Chir       Date:  1973-09

7.  Physiology of erection and pharmacological management of impotence.

Authors:  T F Lue; E A Tanagho
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450

Review 8.  Gene therapy as future treatment of erectile dysfunction.

Authors:  Naoki Yoshimura; Ryuichi Kato; Michael B Chancellor; Joel B Nelson; Joseph C Glorioso
Journal:  Expert Opin Biol Ther       Date:  2010-09       Impact factor: 4.388

Review 9.  Erectile dysfunction.

Authors:  Rany Shamloul; Hussein Ghanem
Journal:  Lancet       Date:  2012-10-05       Impact factor: 79.321

10.  The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury.

Authors:  Derek Bochinski; Gui Ting Lin; Lora Nunes; Rafael Carrion; Nadeem Rahman; Ching Shwun Lin; Tom F Lue
Journal:  BJU Int       Date:  2004-10       Impact factor: 5.588

View more
  5 in total

Review 1.  The emerging role of aldosterone/mineralocorticoid receptors in the pathogenesis of erectile dysfunction.

Authors:  Fei Wu; Yun Lin; Qingyong Liu
Journal:  Endocrine       Date:  2018-05-02       Impact factor: 3.633

Review 2.  Military genitourinary injuries: past, present, and future.

Authors:  Felicia L Balzano; Steven J Hudak
Journal:  Transl Androl Urol       Date:  2018-08

3.  Randomized Placebo Controlled Trial of Sildenafil Citrate, Cognitive Behavior Sex Therapy and Integrated Treatment in Men Diagnosed With Non Organic Erectile Dysfunction.

Authors:  Ahmad Bilal; Najam Ul Hasan Abbasi
Journal:  Sex Med       Date:  2021-12-16       Impact factor: 2.491

Review 4.  Increase in Direct-to-Consumer Telemedicine in Urology.

Authors:  Erin Jesse; Nannan Thirumavalavan; Aram Loeb
Journal:  Curr Sex Health Rep       Date:  2022-08-05

5.  A syndrome of erectile dysfunction in young men?

Authors:  Amanda B Reed-Maldonado; Tom F Lue
Journal:  Transl Androl Urol       Date:  2016-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.